Why is "Effexor" trending?
Latest news, Wikipedia summary, and trend analysis.
Trend Analysis
- Ranking position: #
- Date: 2026-03-22 06:44:19
This topic has appeared in the trending rankings 1 time(s) in the past year. While it does not trend frequently, its appearance suggests a renewed or concentrated surge of public interest.
Based on Wikipedia pageviews and search interest, this topic gained significant attention on the selected date.
Trend Insight
This topic is not currently in the ranking.
Wikipedia Overview
Venlafaxine, sold under the brand name Effexor among others, is an antidepressant medication of the serotonin–norepinephrine reuptake inhibitor (SNRI) class. It is used to treat major depressive disorder, generalized anxiety disorder, panic disorder, and social anxiety disorder. Studies have shown that venlafaxine improves post-traumatic stress disorder (PTSD) as a recommended first-line treatment. It may also be used for chronic neuropathic pain. It is taken orally. It is also available as the salt venlafaxine besylate in an extended-release formulation.
Read more on Wikipedia →Related Topics
Trending Topic Today
Search Interest Perspective
-
How Effexor’s New GAD Approval And MR-139 Setback At Viatris (VTRS) Has Changed Its Investment Story - simplywall.st
-
Viatris’ Effexor Approved in Japan for Generalized Anxiety Disorder - Contract Pharma
-
Viatris Advances Innovative Portfolio with Approval of Effexor® in Japan for Adults with Generalized Anxiety Disorder (GAD) - Yahoo Finance
-
How To Stop Venlafaxine: Very, VERY Slowly! - The People's Pharmacy
-
Effexor Side Effects Women Over 50 Need to Know—Plus How to Manage Them - Woman's World
-
WhiteSands Treatment Center Publishes New Resource on Effexor Withdrawal Risks and Clinical Safety - Knoxville News Sentinel
-
Venlafaxine Found Comparable to Lithium for Bipolar II Maintenance Therapy - Psychiatry Online
-
Effexor side effects women over 50 need to know—plus how to manage them - MSN
-
Viatris wins Japan approval for Effexor to treat anxiety disorder - Investing.com
-
After quitting antidepressants, some people suffer surprising, lingering symptoms - NPR
-
Viatris Says Japan Regulator Approves Effexor for Generalized Anxiety Disorder in Adults - marketscreener.com
-
Viatris announces approval for Effexor SR 37.5 mg / 75 mg capsules in Japan - TipRanks
-
Viatris's Effexor GAD Approval in Japan: A First-in-Class Win or Overpriced Incremental Move? - Bitget
-
Viatris Files Supplemental New Drug Applications to Japan's Ministry of Health, Labor and Welfare for the Approval of EFFEXOR® for the Treatment of Generalized Anxiety Disorder - PR Newswire
-
Follow These Tips for Relieving Constipation Caused by Antidepressants - Verywell Mind
-
After quitting antidepressants, some people suffer surprising, lingering symptoms - NPR
-
Can You Mix Caffeine and Antidepressants or Anti-Anxiety Medications? - Everyday Health
-
Effexor’s Link To Dangerous Spikes In Blood Pressure - MedShadow Foundation
-
What Does It Feel Like to Take Effexor for Depression? - GoodRx
-
Effexor XR side effects: What they are and how to manage them - Medical News Today
-
Effexor XR interactions: Other medications, alcohol, and more - Medical News Today
-
What You Should Know Before Taking Effexor (Venlafaxine) - Verywell Mind
-
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims - Reuters
-
Viatris files applications in Japan for approval of Effexor to treat GAD - Pharmaceutical Business review -
-
Pfizer’s Wyeth reaches $39 million settlement in Effexor XR antitrust case - Reuters
-
Signs Wellbutrin Is Working for You - GoodRx
-
Viatris Announces Positive Top-line Results from Phase 3 Study of EFFEXOR® in Japanese Adults with Generalized Anxiety Disorder (GAD) - PR Newswire
-
Suicidality Emerging From Rapid Venlafaxine Discontinuation: A Challenge–Dechallenge–Rechallenge Case Report - Psychiatrist.com
-
Effexor Lawsuits - Link To Birth Defects, Closed Cases & MDL - Drugwatch.com
-
Pfizer agrees to $39M settlement to resolve Effexor antitrust claims - Top Class Actions
-
Development of Obsessive-Compulsive Symptoms Following Abrupt Discontinuation of Venlafaxine - Frontiers
-
Venlafaxine treatment reduces the deficit of executive control of attention in patients with major depressive disorder - Nature
-
Venlafaxine antagonizes the noradrenaline-promoted colon cancer progression by inhibiting the norepinephrine transporter - Nature
-
The 4 Most Effective Medications for PTSD - GoodRx
-
Combining Aripiprazole, Venlafaxine Reduces Depressive Symptoms in Older Adults - Psychiatry Online
-
Some Antidepressants Tied to Very Specific Birth Defects - MedPage Today
-
Pfizer recalls 104,000 bottles of antidepressant Effexor XR - Fierce Pharma
-
Venlafaxine in Treatment Resistant Obsessive-Compulsive Disorder - Psychiatry Online
-
Venlafaxine Augmentation With Lithium Leading to Serotonin Syndrome - Psychiatry Online
-
Side Effects of Effexor, Similar Antidepressants, May Increase Bipolar Disorder Risks: Study - AboutLawsuits.com
-
Amitriptyline vs Venlafaxine for Reducing Migraine Attacks: Which Is Better? - Neurology Advisor
-
How I Overcame an Episode of SSRI-Induced Suicidal Depression - Mad In America
-
Two-drug combo helps older adults with hard-to-treat depression - WashU
-
Venlafaxine-induced serotonin syndrome causing bilateral cerebral strokes: a case report - Frontiers
-
Lawsuit Says Effexor Caused Life-Threatening Heart Defects in Baby - Top Class Actions
-
Neurodevelopment of Children Following Prenatal Exposure to Venlafaxine, Selective Serotonin Reuptake Inhibitors, or Untreated Maternal Depression - Psychiatry Online
-
Pfizer Settles Remaining Effexor XR Antitrust Claims for $25.5 Million - PYMNTS.com
-
SNRI Effexor SR Capsules obtained approval in Japan - BioWorld News
-
Viatris (VTRS) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $VTRS - MarketBeat
-
Switching Antidepressants: 5 Things to Know (With Chart) - GoodRx
-
Which antidepressants cause the most weight gain? - Medical News Today
-
Couple Sues Pfizer Over Child’s Alleged Effexor Birth Defects - Top Class Actions
-
Venlafaxine and Trazodone: Valid Treatment Options for Major Depressive Disorder - Psychiatry Advisor
-
Bias found when drug manufacturers fund clinical trials - Ohio State News
-
Dr. Drug Rep (Published 2007) - The New York Times
-
Teva agrees to $2.5 million settlement in Effexor XR antitrust class action lawsuit - Claim Depot
-
3 lots of antidepressant Effexor XR recalled - WLWT
-
Antidepressant Recall Due to Cardiac Drug Presence - Medical Professionals Reference
-
Sherry Julo, Ed White and John Read – Online Support Groups for Psychiatric Drug Withdrawal - Mad In America
-
Pfizer recalls lots of brand name and generic Effexor anti-depressant: Food and Drug recalls - Cleveland.com
-
Acute Allergic Angioedema in Woman, 81, Likely Triggered by Effexor XR - Angioedema News
-
The Combined Treatment of Venlafaxine and Quetiapine for Treatment-Resistant Depression: A Clinical Study - Psychiatry Online
-
Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M - Fierce Pharma
-
Here’s Why the Heat Can Feel So Much Worse When You’re Taking an SSRI - SELF Magazine
-
Effexor (R) Xr Approved for the Treatment of Social Anxiety Disorder | Newswise - Newswise
-
Alembic releases generic Effexor - Drug Store News
-
Effexor Birth Defect Lawsuits Set to Move Forward - Top Class Actions
-
Do antidepressants really work? Major new study confirms - CBS News
-
Hooked On Antidepressants - SELF Magazine
-
Lawsuits Allege Effexor Causes Birth Defects - Top Class Actions
-
Antidepressant-Related Adverse Effects Improve with Time - American Academy of Family Physicians | AAFP
-
Effexor Birth Defect Lawsuit Filed Against Pfizer - Top Class Actions
-
Antidepressant shortages cause anxiety for patients with mental illnesses - CBC
-
Tramadol vs. Everything: 744 Drug Interactions and Counting - Lippincott Home
-
When Patients (Disastrously) Go Off Their Psych Medications - HealthCentral
-
Effexor Birth Defect Lawsuits - AboutLawsuits.com
-
Birth Defects Lawsuit Blames Effexor for Stillbirth - Top Class Actions
-
When a Drug Coupon Helps You but Hurts Fellow Citizens (Published 2017) - The New York Times
-
Depression medication recalled after possible ‘metal shaving’ in a tablet - Miami Herald
-
Ky. Couple Sues Pfizer Over Daughter’s Effexor Birth Defects - Top Class Actions
-
Venlafaxine associated with increased risk of suicide and attempted suicide - Managed Healthcare Executive
-
Pfizer, Wyeth Hit with Effexor Birth Defect Lawsuit by Mo. Couple - Top Class Actions
-
Pfizer recalls depression drug in US - PMLiVE
-
Study Indicates Effexor Linked to Birth Defects - Top Class Actions
-
People are hacking antidepressant doses to avoid withdrawal - New Scientist
-
In Postpartum Depression, Effective Care Is Often Out of Reach - Medscape
-
Effexor Birth Defect Lawsuit Alleges Severe Heart Problems in Babies - Top Class Actions
-
Ohio Mother Sues Wyeth for Daughter’s Effexor Birth Defects - Top Class Actions
-
Pristiq's the newest entry in the antidepressant market-buyer beware. - Psychology Today
-
Common Back Pain Treatment Doesn’t Actually Work, Study Finds - Gizmodo
-
Getting off Adderall and reducing antidepressants - 1A | Speak Freely
-
Study: Most Antidepressants Don't Work on Teens or Kids - U.S. News & World Report
-
These popular antidepressants cause the most weight gain: Harvard research - New York Post
-
Hot flashes, what works and what doesn’t? - Cleveland.com
-
Pfizer recalls bottles of antidepressant that might have a heart drug mixed in - Fierce Pharma
-
What Other Drugs Boost Antidepressants’ Effectiveness? - The People's Pharmacy
-
Most antidepressants ineffective in teens, study finds - CBS News
-
Estrogen? Antidepressants? Black cohosh? - Fred Hutchinson Cancer Center
-
Estimates of Serotonin and Norepinephrine Transporter Inhibition in Depressed Patients Treated with Paroxetine or Venlafaxine - Nature
-
Baby deaths spark fears over antidepressants - CBC
Why This Topic Is Trending
This topic has recently gained attention due to increased public interest. Search activity and Wikipedia pageviews suggest growing global engagement.
Search Interest & Related Topics
Search interest data over the past 12 months indicates that this topic periodically attracts global attention. Sudden spikes often correlate with major news events, public statements, or geopolitical developments.